Determining cardiovascular risk in patients with rheumatoid arthritis: prove the efficacy of interventions first
Thomas, S.
NederlandsTijdschriftVoorGeneeskunde 155(30-31):A3563
2011
ISSN/ISBN: 1876-8784 PMID: 22085518 Document Number: 655342
In the multidisciplinary Dutch guideline on Cardiovascular Risk Management (revision 2011) the recommendation for preventive treatment of elevated risks of cardiovascular disease in patients with arthritis lacks a trial-based justification. This section should therefore be removed. Introduction of clinical guidelines with recommendations justified by evidence of an unacceptably low grade is a growing international tendency that should be stopped.
Document emailed within 1 workday
Related Documents
Haye Salinas, M.ía.J.; Bertoli, A.M.; Lema, L.; Saucedo, C.; Rosa, J.; Quintana, R.; Bellomio, V.ón.; Aguero, S.; Spindler, W.; Tamborenea, M.ía.N.; Schimid, M.; Ceccato, F.; Sala, J.é P.; Paira, S.; Spindler, A.; Soriano, E.R.; Estel, B.A.P.; Caeiro, F.; Alvarellos, A.; Saurit, V.ón. 2013: Prevalence of dyslipidemia and elevated cardiovascular risk in patients with rheumatoid arthritis Medicina 73(1): 26-30Nossent, H. 2000: Risk of cardiovascular events and effect on mortality in patients with rheumatoid arthritis Journal of Rheumatology 27(9): 2282-2283
Santos, M.J.é; Vinagre, F.; Silva, J.é J.é; Gil, V.; Fonseca, J.ão.E. 2010: Cardiovascular risk profile in systemic lupus erythematosus and rheumatoid arthritis: a comparative study of female patients Acta Reumatologica Portuguesa 35(3): 325-332
García-Bermúdez, M.; González-Juanatey, C.; Rodríguez-Rodríguez, L.; Miranda-Filloy, J.A.; Perez-Esteban, S.; Vazquez-Rodriguez, T.R.; Castañeda, S.; Balsa, A.; Fernández-Gutierrez, B.; Llorca, J.; González-Alvaro, I.; Martín, J.; González-Gay, M.A. 2011: Lack of association of NAMPT rs9770242 and rs59744560 polymorphisms with disease susceptibility and cardiovascular risk in patients with rheumatoid arthritis Clinical and Experimental Rheumatology 29(4): 681-688
Rosales-Alexander, J.L.; Salvatierra, J.; Llorca, J.; Magro-Checa, C.; González-Gay, M.A.; Cantero-Hinojosa, J.; Raya-Álvarez, E. 2014: Cardiovascular risk assessment in rheumatoid arthritis: impact of the EULAR recommendations on a national calibrated score risk index Clinical and Experimental Rheumatology 32(2): 237-242
Rebrov, A.P.; Nikitina, N.M.; Gaĭdukova, I.Z. 2011: Cardiovascular risk factors in psoriatic and rheumatoid arthritis Terapevticheskii Arkhiv 83(5): 20-24
McCarey, D.; Sturrock, R.D. 2009: Comparison of cardiovascular risk in ankylosing spondylitis and rheumatoid arthritis Clinical and Experimental Rheumatology 27(4 Suppl 55: S124-S126
Cleland, L.G.; Caughey, G.E.; James, M.J.; Proudman, S.M. 2006: Reduction of cardiovascular risk factors with longterm fish oil treatment in early rheumatoid arthritis Journal of Rheumatology 33(10): 1973-1979
Gonzalez-Gay, M.A.; Llorca, J.; Palomino-Morales, R.; Gomez-Acebo, I.; Gonzalez-Juanatey, C.; Martin, J. 2009: Influence of nitric oxide synthase gene polymorphisms on the risk of cardiovascular events in rheumatoid arthritis Clinical and Experimental Rheumatology 27(1): 116-119
Gonzalez-Gay, M.A.; Llorca, J.; Garcia-Unzueta, M.T.; Gonzalez-Juanatey, C.; De Matias, J.M.; Martin, J.; Redelinghuys, M.; Woodiwiss, A.J.; Norton, G.R.; Dessein, P.H. 2008: High-grade inflammation, circulating adiponectin concentrations and cardiovascular risk factors in severe rheumatoid arthritis Clinical and Experimental Rheumatology 26(4): 596-603
Trusov, V.V.; Bazhenov, A.N. 1989: Importance of determining the beta2-microglobulin level in biological fluids in patients with rheumatoid arthritis Terapevticheskii Arkhiv 61(5): 46-48
Lemmel, E.M.; Bolten, W.; Burgos-Vargas, R.; Platt, P.; Nissilä, M.; Sahlberg, D.; Björneboe, O.; Baumgartner, H.; Valat, J.P.; Franchimont, P.; Bluhmki, E.; Hanft, G.; Distel, M. 1997: Efficacy and safety of meloxicam in patients with rheumatoid arthritis Journal of Rheumatology 24(2): 282-290
Saraswathi, P.V.; Neelambikai, N.; Mahesh, A.; Govindarajan, K. 2013: Cardiovascular parasympathetic nervous system dysfunction in female rheumatoid arthritis patients Indian Journal of Physiology and Pharmacology 57(1): 23-30
Kurowski, M.; Menninger, H.; Pauli, E. 1994: The efficacy and relative bioavailability of diclofenac resinate in rheumatoid arthritis patients International Journal of Clinical Pharmacology and Therapeutics 32(8): 433-440
Drosos, A.A.; Voulgari, P.V. 2001: Long-term efficacy and toxicity of a combination therapy in rheumatoid arthritis patients Clinical and Experimental Rheumatology 19(1): 111
Schwemmer, S.; Beer, P.; Schölmerich, J.; Fleck, M.; Straub, R.H. 2006: Cardiovascular and pupillary autonomic nervous dysfunction in patients with rheumatoid arthritis - a cross-sectional and longitudinal study Clinical and Experimental Rheumatology 24(6): 683-689
Shinozawa, T.; Kameda, H.; Hama, N.; Yoshida, T.; Ohosone, Y.; Ichikawa, Y. 1998: The efficacy of combination therapy with prednisolone (PSL) and methotrexate (MTX) on radiographic progression in patients with rheumatoid arthritis (RA) Ryumachi 38(1): 14-22
Voloshyn, O.I.; Pishak, O.V.; Seniuk, B.P.; Cherniavs'ka, N.B. 1998: The efficacy of flower pollen in patients with rheumatoid arthritis and concomitant diseases of the gastroduodenal and hepatobiliary systems Likars'ka Sprava 4: 151-154
Alekseeva, L.I. 2010: Comparative evaluation of the safety and efficacy of etoricoxib and diclofenac on the upper gastrointestinal tract in patients with osteoarthrosis and rheumatoid arthritis (the multinational etoricoxib and diclofenac arthritis long-term (MEDAL) study program) Terapevticheskii Arkhiv 82(8): 57-62
Shostak, N.A.; Muradiants, A.A.; Kondrashov, A.A.; Denisova, S.N. 2014: Clinical efficacy instant goat milk in the complex therapy and prevention of osteoporosis in patients with rheumatoid arthritis Voprosy Pitaniia 83(5): 79-85